Duane Reade Sale Reflects “Industry Issues”: Rx-To-OTC “Shifts” Cited
This article was originally published in The Tan Sheet
Executive Summary
Market shift from Rx-to-OTC products is among pharmacy industry issues cited by the retail drug chain Duane Reade in explaining its decision to sell to the private equity firm Oak Hill Capital Partners